Shionogi
Evan Colman is a seasoned professional in market access and healthcare marketing with over three decades of experience. Currently serving as Senior Director of Value & Access Marketing at Shionogi Inc. since March 2024, Colman previously held leadership roles at Intercept Pharmaceuticals and Bayer Pharmaceuticals, focusing on rare diseases and specialty portfolios. Colman's extensive tenure at Novartis involved multiple positions in Enterprise Access Strategy and Managed Markets, providing strategic direction for patient access and payer marketing. Earlier experience includes significant roles at Merck and Schering-Plough, where strategic marketing and access were prioritized across various therapeutic areas. Colman began a career as a Medical Sales Representative at Wallace Laboratories and holds a B.S. in Marketing from Syracuse University.
This person is not in any teams
This person is not in any offices
Shionogi
10 followers
Shionogi Inc. is the U.S. subsidiary of Shionogi & Co., Ltd., a 140-year-old global pharmaceutical company with headquarters in Osaka, Japan. In the U.S., Shionogi Inc. leverages their science-based heritage to develop and commercialize pharmaceutical products to treat unmet medical needs in our core areas of infectious diseases and pain, as well as other areas of high medical need, including chronic liver disease.